compounded tirzepatide reddit Mounjaro and Reddit: Top Questions Answered Is my compound Tirzepatide working?

Current evidence suggests Mounjaro may produce greater average weight reduction because of its dual GIP and GLP-1 mechanism

Built on top of maximised RAAS (renin-angiotensin-aldosterone system) blockade, SGLT2i remain part of the foundation, recommended broadly for adults with CKD and albuminuria or heart failure, including many without T2D

Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)

Several important considerations apply: Individuals with active or severe gastrointestinal disease may experience worsening symptoms due to the gastrointestinal side effects of GLP-1 medications The slowed gastric emptying caused by these drugs could theoretically exacerbate symptoms in people with strictures or obstructive complications of Crohn's disease Weight loss associated with GLP-1 therapy may be inappropriate in patients with Crohn's disease who are already experiencing malnutrition or unintentional weight loss The interaction between GLP-1 medications and the inflammatory processes in IBD is not fully understood Clinical decision-making should involve a thorough assessment of disease activity, nutritional status, presence of complications (such as strictures or fistulas), and the primary indication for GLP-1 therapy

The first is failing to implement dose escalation properly both compounds carry significant nausea risk at maintenance doses when escalation is skipped or shortened

Choose easily digestible foods , particularly during the first weeks after starting Mounjaro or increasing your dose